Lupin Confident Of US Growth On Tariff Mitigation, Rides High On Tolvaptan

Victoza Generic, Biosimilars Part Of US Growth Plan

Business Growth Strategy
Lupin Is Optimistic Of US Growth Despite Challenges Like Tariffs (Shutterstock)

More from Strategy

More from Business